Literature DB >> 28654719

Everolimus-Based Immunosuppression in Liver Transplant Recipients.

F Saliba1.   

Abstract

Entities:  

Keywords:  calcineurin inhibitor: cyclosporine A (CsA); calcineurin inhibitor: tacrolimus; clinical research/practice; immunosuppressant; liver transplantation/hepatology; mechanistic target of rapamycin: everolimus

Mesh：

Substances：

Year:  2017        PMID： 28654719     DOI： 10.1111/ajt.14388

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  2 in total

1.  Early use of everolimus improved renal function after adult deceased donor liver transplantation.

Authors:  Seohee Lee; Jong Man Kim; Sangjin Kim; Jinsoo Rhu; Gyu-Seong Choi; Jae-Won Joh
Journal:  Korean J Transplant       Date:  2021-02-19

2.  The benefit of everolimus in recurrent/epithelioid angiosarcoma patients: Case reports and literature review.

Authors:  Shi-Long Zhang; Li Liang; Yuan Ji; Zhi-Ming Wang; Yu-Hong Zhou
Journal:  Oncotarget       Date:  2017-10-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.